SCHEMBL6352671

SCHEMBL6352671

CCCCN(CC)S(=O)(=O)c1ccc(C(=O)Nc2ccc(C#N)cc2C(=O)O)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.58
LMNA P02545 5/20 0.58
ALDH1A1 P00352 4/20 0.58
ALB P02768 1/20 0.55
ALOX15 P16050 4/20 0.49
HTT P42858 4/20 0.49
TDP1 Q9NUW8 3/20 0.49
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
KDM4E B2RXH2 3/20 0.49
TP53 P04637 3/20 0.49
USP2 O75604 2/20 0.49
TSHR P16473 1/20 0.49
POLB P06746 2/20 0.49
MAPT P10636 2/20 0.49
P4HB P07237 2/20 0.48
APEX1 P27695 1/20 0.48
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CA12 O43570 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6353196 0.93 ALB (0.53) SMN1; SMN2LMNAALDH1A1ALBALOX15
SCHEMBL6359345 0.93 ALB (0.53) SMN1; SMN2LMNAALDH1A1ALBALOX15
SCHEMBL6352948 0.90 APEX1 (0.63) SMN1; SMN2LMNAALDH1A1ALBMEN1
SCHEMBL6359077 0.84 ALB (0.56) SMN1; SMN2LMNAALDH1A1ALBALOX15
SCHEMBL6353472 0.83 APEX1 (0.56) SMN1; SMN2LMNAALDH1A1ALBMEN1
SCHEMBL6357082 0.83 APEX1 (0.56) SMN1; SMN2LMNAALDH1A1ALBMEN1
SCHEMBL6353693 0.82 ALB (0.55) SMN1; SMN2LMNAALDH1A1ALBHTT
SCHEMBL6821593 0.81 LMNA (0.39) SMN1; SMN2LMNAALDH1A1ALBMEN1
SCHEMBL6352320 0.80 TAS2R14 (0.57) SMN1; SMN2LMNAALDH1A1ALBMEN1
SCHEMBL6352988 0.80 TAS2R14 (0.56) SMN1; SMN2LMNAALDH1A1ALBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 SMN1; SMN2 3015/4885LMNA 4552/4885ALDH1A1 462/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.